Clinical Evaluation of Alvimopan (SB767905) on Constipation and Related Symptoms Associated With Opioid -A Placebo-Controlled Double-Blind Study in Cancer Patients-

Trial Profile

Clinical Evaluation of Alvimopan (SB767905) on Constipation and Related Symptoms Associated With Opioid -A Placebo-Controlled Double-Blind Study in Cancer Patients-

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Nov 2015

At a glance

  • Drugs Alvimopan (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Cubist Pharmaceuticals; GlaxoSmithKline
  • Most Recent Events

    • 01 Sep 2015 Status changed from completed to discontinued as per ClinicalTrials.gov record.
    • 21 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top